Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0221002 (primary hyperparathyroidism)
 4,921 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

On the basis of a dramatic hypercalcemia revealed by digestive and neuropsychic symptoms and related to a primary hyperparathyroidism, the authors recall all the clinical circumstances which should lead to determination of plasma calcium as well as the clinical and biological particularities which, in front of a hypercalcemia, suggest a primary hyperparathyroidism. The stress the usefulness and the limits of the dosage of plasma immunoreactive parathyroid hormone as well as the difficulties to differentiale primary from paraneoplasic hyperparathyroidism. The recent pathophysiological concepts of malignant hypercalcemia reviewed.
Sem Hop
PMID:[Primary hyperparathyroidism. Current aspects of its diagnosis apropos of a case with digestive and neuropsychiatric manifestations]. 21 10

In order to evaluate the relationship between apparently idiopathic osteoporosis and parathyroid hormone secretion, plasma immunoreactive parathyroid hormone (iPTH) was measured in 57 untreated osteoporotic patients using a carboxyl-terminal specific antiserum, and sections of undecalcified iliac bone biopsies from these subjects, who had been previously doubly labelled with tetracycline, were quantitatively analysed. Twenty-one patients (36%) exhibited histological signs of a high remodeling similar to that which is present in primary hyperparathyroidism, but their osteoplastic appositional rate values were lower. Among these 21 cases 8 had an increase of their iPTH levels. These data and those of the literature indicate that in a few cases high remodeling osteoporosis may be associated with parathyroid hypersecretion, but do not bring out the evidence that the increased circulating iPTH is the cause of osteoporosis. The authors draw from their results some practical consequences for the treatment of high remodeling osteoporosis.
Sem Hop
PMID:[Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)]. 625 48

Twenty-one patients in a series of 283 treated surgically for primary hyperparathyroidism between 1960 and 1982, underwent reoperation. Eleven had been previously treated elsewhere. The initial cervicotomy was negative in fourteen cases, but had led to the ablation of one or more adenomas in seven. The reason for reoperation was recurrence or persistence of hyperparathyroidism (HPT). It was commenced by cervicotomy in the eleven patients initially treated elsewhere, and by cervicotomy and/or sternotomy for the others. Reoperation involved ablation of adenomas in thirteen cases, but was negative in the remaining eight. Three of the eight underwent a second reoperation, with success in two cases. Overall, reoperations led to ablation of sixteen adenomas in fifteen patients. Ten adenomas were ectopic, including eight located mediastinally . Ten sternotomies were performed, leading to ablation of four mediastinal adenomas. Postoperative complications included five recurrent paralyses and two severe cases of hypocalcemia. One patient with parathyroidal carcinoma died of malignant hypercalcemia. Fifteen of the twenty one patients (71%) were cured of their HPT. Basing themselves on these cases, and a review of the literature, the authors describe the indications and practical management of reoperative surgery for primary HPT.
Sem Hop 1984 May 03
PMID:[Reoperation for primary hyperparathyroidism]. 632 25